Betta Pharmaceuticals Co (SZSE:300558) Price-to-Tangible-Book : 8.82 (As of May. 16, 2024)

View and export this data going back to 2016. Start your Free Trial

What is Betta Pharmaceuticals Co Price-to-Tangible-Book?

As of today (2024-05-16), Betta Pharmaceuticals Co's share price is ¥40.51. Betta Pharmaceuticals Co's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was ¥4.59. Hence, Betta Pharmaceuticals Co's Price to Tangible Book Ratio of today is 8.82.

The historical rank and industry rank for Betta Pharmaceuticals Co's Price-to-Tangible-Book or its related term are showing as below:

SZSE:300558' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 8.81 Med: 21.07 Max: 99.49
Current: 8.83

During the past 13 years, Betta Pharmaceuticals Co's highest Price to Tangible Book Ratio was 99.49. The lowest was 8.81. And the median was 21.07.

SZSE:300558's Price-to-Tangible-Book is ranked worse than
89.62% of 867 companies
in the Drug Manufacturers industry
Industry Median: 2.37 vs SZSE:300558: 8.83

A closely related ratio is called PB Ratio. As of today, Betta Pharmaceuticals Co's share price is ¥40.51. Betta Pharmaceuticals Co's Book Value per Sharefor the quarter that ended in Mar. 2024 was ¥13.20. Hence, Betta Pharmaceuticals Co's P/B Ratio of today is 3.07.

Betta Pharmaceuticals Co Price-to-Tangible-Book Historical Data

The historical data trend for Betta Pharmaceuticals Co's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Betta Pharmaceuticals Co Price-to-Tangible-Book Chart

Betta Pharmaceuticals Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

41.53

22.72

19.36

11.60

12.88

Betta Pharmaceuticals Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Tangible-Book	Get a 7-Day Free Trial															13.59	11.50	12.41	12.88	8.91

Competitive Comparison of Betta Pharmaceuticals Co's Price-to-Tangible-Book

For the Drug Manufacturers - Specialty & Generic subindustry, Betta Pharmaceuticals Co's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Betta Pharmaceuticals Co's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Betta Pharmaceuticals Co's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Betta Pharmaceuticals Co's Price-to-Tangible-Book falls into.

Betta Pharmaceuticals Co Price-to-Tangible-Book Calculation

Betta Pharmaceuticals Co's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Mar. 2024 )
	=	40.51	/	4.591
	=	8.82

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Betta Pharmaceuticals Co Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Betta Pharmaceuticals Co's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Betta Pharmaceuticals Co (SZSE:300558) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Betta Pharmaceuticals Co Ltd (SZSE:300558) » Definitions » Price-to-Tangible-Book

Traded in Other Exchanges

N/A

Address

No.355, Xingzhong Road, Yuhang Economic and Technological Development Zone, Zhejiang Province, Hangzhou, CHN

Website

http://www.bettapharma.com

Betta Pharmaceuticals Co Ltd is a hi-tech pharmaceutical enterprise focuses on research and development of innovative medicines. The company's drug is used for various diseases such as malignant tumors, diabetes, and cardio-cerebrovascular disease. Further, it offers Icotinib hydrochloride, an orally administered small-molecule and a reversible tyrosine kinase inhibitor, which is used for the treatment of non-small-cell lung cancer. Geographically, the group operates through China.

Betta Pharmaceuticals Co (SZSE:300558) Headlines

No Headlines